DRDO’s anti-Covid drug 2DG launched

New Delhi, 17/5 (AO Bureau):The first batch of DRDO’s anti-Covid drug 2DG has been launched. 2DG is the first drug called anti-Covid drug. DCGI approved the emergency use of this medicine only last week. This drug is being seen as a game-changer in the fight against this epidemic, as it helps in rapid recovery of hospitalized patients and also reduces oxygen support. Defense Minister Rajnath Singh has launched the first batch of DRDO’s anti-Covid drug 2DG for patients with coronavirus. Union Health Minister Dr. Harsh Vardhan and AIIMS Director Dr. Randeep Guleria were also present in the program.

Know everything about 2-DG

Manufacturer: The drug has been developed by the Institute of Nuclear Medicine and Allied Sciences (INMAS), a laboratory of the Defense Research and Development Organization (DRDO). Hyderabad-based Dr. Reddy’s Laboratories has been a partner and is manufacturing the drug for public use.

How does medicine work?

DRDO Chief G. Satish Reddy said that this drug will work directly on the shells infected with coronavirus. The immune system of the body will work and the patient will recover quickly. It is a glucose analog, which resembles glucose, but is not. A virus growing rapidly in the body needs glucose for energy. Thus, the virus will take this glucose analog and neutralize. The drug will then stop the virus from growing.

Comments are closed.